Our mission is to become a worldwide reference for education in the field for all professionals involved in the process to disseminate knowledge & skills of Acute Cardiovascular Care.
Our mission is to promote excellence in clinical diagnosis, research, technical development, and education in cardiovascular imaging in Europe.
Our mission is to promote excellence in research, practice, education and policy in cardiovascular health, primary and secondary prevention.
Our mission is to reduce the burden of cardiovascular disease through percutaneous cardiovascular interventions.
Improving the quality of life and reducing sudden cardiac death by limiting the impact of heart rhythm disturbances.
Our mission is to improve quality of life and longevity, through better prevention, diagnosis and treatment of heart failure, including the establishment of networks for its management, education and research.
The ESC Working Groups' goal is to stimulate and disseminate scientific knowledge in different fields of cardiology.
The ESC Councils' goal is to share knowledge among medical professionals practising in specific cardiology domains.
The sensational news on Sunday 4 November was the TRITON trial which demonstrated that in 13,608 STEMI/non STEMI patients treated invasively and followed for a year with prasugrel versus clopodigrel, the stronger prasugrel led to significantly less myocardal infarctions, yet had no incidence on strokes or deaths.
Stent thrombosis was halved by prasugrel compared to clopidogrel. However severe bleeding was increased by 32% by prasugrel which may hamper its general use in interventional therapy for (N)STEMI patients.
American Heart Association
Our mission: To reduce the burden of cardiovascular disease
© 2017 European Society of Cardiology. All rights reserved